Literature DB >> 22370825

Active surveillance of American tegumentary leishmaniasis in endemic areas in rural Bolivia.

Vladimir Luna Tedesqui1, Guido Noel Chuquimia Calleja, Rolando Parra, Javier Palacios Pabón, Márcio Neves Bóia, Filipe Anibal Carvalho-Costa.   

Abstract

INTRODUCTION: American tegumentary leishmaniasis (ATL), including mucocutaneous leishmaniasis (MCL) and localized cutaneous leishmaniasis (LCL), is endemic in Bolivia. We describe the results of active surveillance of ATL from 2001 to 2006 and assess demographic data related to ATL epidemiology in the Yungas valleys.
METHODS: Community-based active ATL surveillance was performed by the institutions SERVIR, CÁRITAS, and the Health Services Department of La Paz, whose files were reviewed retrospectively. A cross-sectional survey was carried out to assess demographic data in two communities.
RESULTS: Two thousand nine hundred nine cases of ATL were detected from 2001 to 2006: 2,488 (85.5%) corresponded to LCL and 421 (14.5%) to MCL. A reduction in the proportion of mucosal cases was observed between 2001 and 2006. The proportion of MCL cases increased with age and was higher among males (15.5% versus 12.1%, p=0.018). The rate of positivity via direct observation of the parasite in dermal scrapings and in parasite cultivation was significantly higher for LCL than for MCL (p<0.001 and p=0.009, respectively). The rate of reactivity in the leishmanin skin test was higher in the group with mucosal lesions (p=0.012). The cross-sectional survey showed that 40% of the families had emigrated from the Altiplano.
CONCLUSIONS: It is necessary to undertake continuous case detection of ATL in the area, where the disease presents a high rate of mucosal cases. Increasing incidence seems to be associated with immigration and continuous deforestation to expand the crop-growing areas.

Entities:  

Mesh:

Year:  2012        PMID: 22370825     DOI: 10.1590/s0037-86822012000100007

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  5 in total

1.  The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.

Authors:  Kristina M Bacon; Peter J Hotez; Stephanie D Kruchten; Shaden Kamhawi; Maria Elena Bottazzi; Jesus G Valenzuela; Bruce Y Lee
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

Review 2.  Mucosal leishmaniasis: an underestimated presentation of a neglected disease.

Authors:  Alessio Strazzulla; Salvatore Cocuzza; Marilia Rita Pinzone; Maria Concetta Postorino; Stefano Cosentino; Agostino Serra; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

3.  Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes.

Authors:  Ana Paula Perez; Agustina Casasco; Priscila Schilrreff; Maria Victoria Defain Tesoriero; Luc Duempelmann; Juan Sebastián Pappalardo; Maria Julia Altube; Leticia Higa; Maria Jose Morilla; Patricia Petray; Eder L Romero
Journal:  Int J Nanomedicine       Date:  2014-07-10

4.  Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.

Authors:  Cristina Ballart; Mary Cruz Torrico; Gisela Vidal; Faustino Torrico; Daniel Lozano; Montserrat Gállego; Lilian Pinto; Ernesto Rojas; Ruth Aguilar; Carlota Dobaño; Sonia Ares-Gomez; Albert Picado
Journal:  PLoS Negl Trop Dis       Date:  2021-03-05

Review 5.  Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update.

Authors:  Ludovic Reveiz; Ana Nilce Silveira Maia-Elkhoury; Rubén Santiago Nicholls; Gustavo Adolfo Sierra Romero; Zaida E Yadon
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.